"Turkish and American drug firms to test interferon against Behçet's disease
Friday, March 24, 2006
Clinical trial of oral lozenges is first of its kind in Turkey
MICHAEL KUSER
ISTANBUL - Turkish Daily News
A small pharmaceutical company in Texas, Amarillo Biosciences, has licensed a Turkish drug maker to run a clinical trial of its interferon lozenges on Behcet's disease patients in Turkey."
More:Turkish and American drug firms to test interferon against Behçet's disease - Turkish Daily News Mar 24, 2006
